Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest

E. Vaclavikova, S. Dvorakova, V. Sykorova, R. Bilek, K. Dvorakova, P. Vlcek, R. Skaba, T. Zelinka, B. Bendlova

. 2009 ; 36 (3) : 419-424. [pub] 20091014

Jazyk angličtina Země Spojené státy americké

Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12026968

Grantová podpora
NR9165 MZ0 CEP - Centrální evidence projektů

Activating germline RET mutations are presented in patients with familial medullary thyroid carcinoma (FMTC) and multiple endocrine neoplasia (MEN) types 2A and 2B, whereas inactivating germline mutations in patients with Hirschsprung's disease (HSCR). The aim of this study was to evaluate genotype-phenotype correlations of the frequently discussed Tyr791Phe mutation in exon 13 of the RET proto-oncogene. Screening of three groups of patients was performed (276 families with medullary thyroid carcinoma (MTC), 122 families with HSCR, and 29 patients with pheochromocytoma). We found this mutation in 3 families with apparently sporadic MTC, 3 families with FMTC/MEN2, 1 patient with pheochromocytoma, and 3 families with HSCR. All gene mutation carriers have a silent polymorphism Leu769Leu in exon 13. In three families second germline mutations were detected: Cys620Phe (exon 10) in MEN2A family, Met918Thr (exon 16) in MEN2B family, and Ser649Leu (exon 11) in HSCR patient. Detection of the Tyr791Phe mutation in MEN2/MTC and also in HSCR families leads to the question whether this mutation has a dual character (gain-of-function as well as loss-of-function). A rare case of malignant pheochromocytoma in a patient with the Tyr791Phe mutation is presented. This study shows various clinical characteristics of the frequently discussed Tyr791Phe mutation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12026968
003      
CZ-PrNML
005      
20160601083157.0
007      
ta
008      
120816s2009 xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1007/s12020-009-9242-7 $2 doi
035    __
$a (PubMed)19826964
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Václavíková, Eliška. $7 xx0228492 $u Department of Molecular Endocrinology, Institute of Endocrinology, Narodni 8, 116 94, Prague 1, Czech Republic. evaclavikova@endo.cz
245    10
$a RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest / $c E. Vaclavikova, S. Dvorakova, V. Sykorova, R. Bilek, K. Dvorakova, P. Vlcek, R. Skaba, T. Zelinka, B. Bendlova
520    9_
$a Activating germline RET mutations are presented in patients with familial medullary thyroid carcinoma (FMTC) and multiple endocrine neoplasia (MEN) types 2A and 2B, whereas inactivating germline mutations in patients with Hirschsprung's disease (HSCR). The aim of this study was to evaluate genotype-phenotype correlations of the frequently discussed Tyr791Phe mutation in exon 13 of the RET proto-oncogene. Screening of three groups of patients was performed (276 families with medullary thyroid carcinoma (MTC), 122 families with HSCR, and 29 patients with pheochromocytoma). We found this mutation in 3 families with apparently sporadic MTC, 3 families with FMTC/MEN2, 1 patient with pheochromocytoma, and 3 families with HSCR. All gene mutation carriers have a silent polymorphism Leu769Leu in exon 13. In three families second germline mutations were detected: Cys620Phe (exon 10) in MEN2A family, Met918Thr (exon 16) in MEN2B family, and Ser649Leu (exon 11) in HSCR patient. Detection of the Tyr791Phe mutation in MEN2/MTC and also in HSCR families leads to the question whether this mutation has a dual character (gain-of-function as well as loss-of-function). A rare case of malignant pheochromocytoma in a patient with the Tyr791Phe mutation is presented. This study shows various clinical characteristics of the frequently discussed Tyr791Phe mutation.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a substituce aminokyselin $x genetika $7 D019943
650    _2
$a medulární karcinom $x genetika $7 D018276
650    _2
$a dítě $7 D002648
650    _2
$a nemoc $x genetika $7 D004194
650    _2
$a rodina $7 D005190
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetické asociační studie $7 D056726
650    _2
$a zárodečné mutace $7 D018095
650    _2
$a Hirschsprungova nemoc $x genetika $7 D006627
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mnohočetná endokrinní neoplazie typ 2A $x genetika $7 D018813
650    _2
$a crista neuralis $x patologie $7 D009432
650    _2
$a fenylalanin $x genetika $7 D010649
650    _2
$a jednonukleotidový polymorfismus $x fyziologie $7 D020641
650    _2
$a protoonkogenní proteiny c-ret $x genetika $7 D051096
650    _2
$a nádory štítné žlázy $x genetika $7 D013964
650    _2
$a tyrosin $x genetika $7 D014443
650    _2
$a mladý dospělý $7 D055815
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dvořáková, Šárka $7 xx0080456 $u Department of Molecular Endocrinology, Institute of Endocrinology
700    1_
$a Sýkorová, Vlasta $7 xx0118026 $u Department of Molecular Endocrinology, Institute of Endocrinology
700    1_
$a Bílek, Radovan, $d 1954- $7 jo20000074070 $u Department of Proteohormones and Biofactors, Institute of Endocrinology
700    1_
$a Dvořáková, Katerina $u Department of Clinical Endocrinology, Institute of Endocrinology
700    1_
$a Vlček, Petr, $d 1961- $7 xx0003505 $u Department of Nuclear Medicine and Endocrinology, 2nd Faculty of Medicine, Charles University and Teaching Hospital Motol
700    1_
$a Škába, Richard, $d 1949- $7 jn20000402842 $u Department of Pediatric Surgery, 2nd Faculty of Medicine, Charles University and Teaching Hospital Motol
700    1_
$a Zelinka, Tomas $u 3rd Medical Department, Clinical Department of Endocrinology and Metabolism of the First Faculty of Medicine and General Teaching Hospital
700    1_
$a Bendlová, Běla, $d 1962- $7 jo20000074069 $u Department of Molecular Endocrinology, Institute of Endocrinology
773    0_
$w MED00180215 $t Endocrine $x 1559-0100 $g Roč. 36, č. 3 (2009), s. 419-424
856    41
$u https://pubmed.ncbi.nlm.nih.gov/19826964 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20160601083320 $b ABA008
999    __
$a ok $b bmc $g 949010 $s 784314
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2009 $b 36 $c 3 $d 419-424 $e 20091014 $i 1559-0100 $m Endocrine $n Endocrine $x MED00180215
GRA    __
$a NR9165 $p MZ0
LZP    __
$b NLK122 $a Pubmed-20120816/11/01

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace